MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Dave Licata
Dave LicataTORL BIOTHERAPEUTICS LLC

Dave Licata

President and CEO at TORL BIOTHERAPEUTICS LLC

Manager

Deal Bio

Total Deals2
Valued Deals2
Total Value£ 251 M
Avg. Deal Size£ 125 M

Market Context

Sort

13 Apr 2023|United States|Pharmaceuticals
Torl Biotherapeutics
Bristol Myers Squibb Company

Target: TORL BIOTHERAPEUTICS LLC

Bidder: BRISTOL MYERS SQUIBB COMPANY

10 Service Providers

1 Target | 9 Bidder

15 Dealmakers

1 Target | 14 Bidder

£ 126 M

Value

10 Apr 2024|United States|Pharmaceuticals
Torl Biotherapeutics
Deep Track Capital

Target: TORL BIOTHERAPEUTICS LLC

Bidder: DEEP TRACK CAPITAL

4 Service Providers

1 Target | 3 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 124 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite